Strata Skin Sciences Stock Today
| SSKN Stock | USD 2.66 0.05 1.92% |
PerformanceVery Weak
| Odds Of DistressHigh
|
STRATA Skin is selling at 2.66 as of the 21st of March 2025; that is 1.92 percent increase since the beginning of the trading day. The stock's open price was 2.61. STRATA Skin has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 28th of October 2005 | Category Healthcare | Classification Health Care |
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company has 4.17 M outstanding shares of which 590 shares are at this time shorted by private and institutional investors with about 0.47 trading days to cover. More on STRATA Skin Sciences
Moving together with STRATA Stock
Moving against STRATA Stock
STRATA Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Dolev Rafaeli | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsSTRATA Skin can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand STRATA Skin's financial leverage. It provides some insight into what part of STRATA Skin's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
STRATA Skin Sciences (SSKN) is traded on NASDAQ Exchange in USA. It is located in 5 Walnut Grove Drive, Horsham, PA, United States, 19044 and employs 99 people. STRATA Skin is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.89 M. STRATA Skin Sciences conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 4.17 M outstanding shares of which 590 shares are at this time shorted by private and institutional investors with about 0.47 trading days to cover.
STRATA Skin Sciences currently holds about 10.04 M in cash with (519 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29.
Check STRATA Skin Probability Of Bankruptcy
Ownership AllocationThe market capitalization of STRATA Skin is $10.89 Million. Over half of STRATA Skin's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check STRATA Ownership Details
STRATA Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Carmichael Hill & Associates Inc | 2024-09-30 | 300 | |
| Jpmorgan Chase & Co | 2024-12-31 | 106 | |
| Financial Perspectives Inc | 2024-12-31 | 101 | |
| Bank Of America Corp | 2024-12-31 | 20.0 | |
| Hanson Mcclain Inc | 2024-12-31 | 5.0 | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 1.0 | |
| Acadian Asset Management Llc | 2024-12-31 | 0.0 | |
| Northern Trust Investments N A | 2024-12-31 | 0.0 | |
| Fmr Inc | 2024-09-30 | 0.0 | |
| 22nw, Lp | 2024-12-31 | 537 K | |
| Nantahala Capital Management, Llc | 2024-12-31 | 403.9 K |
STRATA Skin Historical Income Statement
STRATA Stock Against Markets
STRATA Skin Corporate Management
| Shmuel Gov | Chief Officer | Profile | |
| John Gillings | Principal Officer | Profile | |
| Robert Moccia | CEO Pres | Profile | |
| William MBA | Ex Chairman | Profile | |
| Michael Goodman | Head Sales | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.60) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets | Return On Equity |
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.